Consolidated Statements of Cash Flow (Unaudited) - USD ($)	3 Months Ended
	Nov. 30, 2021	Nov. 30, 2020
Cash flows from operating activities:
Net income (loss)	$ (239,853)	$ (237,268)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	0	430
(Gain) Loss on change in fair value of derivative liability	0	173,154
Impairment expense	17,598	0
Gain on extinguishment of debt	(143,956)	0
Realized income on investment	0	(2,087)
Changes in operating assets and liabilities:
Accounts receivable	0	(3,080)
Inventory	0	1,000
Prepaid expenses	(1,450)	4,945
Notes receivable	0	28,820
Accounts payable	(22,745)	45,529
Accrued expenses	101,242	0
Related party payable	(64,600)	226
Net cash provided by (used in) operating activities	(353,764)	11,669
Cash flows from investing activities:
Cash paid for asset purchase	(350,000)	0
Notes receivable investment	(500,000)	0
Net cash used in investing activities	(850,000)	0
Cash flows from financing activities
Proceeds form series B-1 preferred stock purchase agreements	4,000,000	0
Net cash provided by financing activities	4,000,000	0
Net increase (decrease) in cash	2,796,236	11,669
Cash - beginning of the year	137,476	17,881
Cash - end of the year	2,933,712	29,550
Supplemental disclosures:
Interest paid	0	0
Income taxes	0	0
Non-cash transactions:
Preferred stock dividends accrued	136,887	12,575
Common Stock issued for asset purchase	$ 40,654,827	$ 0